Study details
Enrolling now
Biomarkers Research in Anxiety for Validation and Efficacy
Boston Children's Hospital
NCT IDNCT06221176ClinicalTrials.gov data as of Apr 2026
Target enrollment
25
Study length
about 1.3 years
Ages
3–6
Locations
1 site in MA
About this study
Researchers are testing a treatment called 'Being Brave' to see if it can help children with autism or autism spectrum disorder. The trial will look at four different biomarkers, which are signs that show how well the treatment is working.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Being Brave
Primary goalSpence Preschool Anxiety Scale (SPAS) or Spence Anxiety Scale (SCAS) Parent Report
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low7%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Spence Preschool Anxiety Scale (SPAS) or Spence Anxiety Scale (SCAS) Parent Report
Body systems
Psychiatry / Mental Health